Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Association of Serum Vitamin D and Total Antioxidant Capacity Levels With Stress and Anxiety in Young Female Students

Samira Hashemi 1 , Reza Amani 2 , 3 , * , Bahman Cheraghian 4 , Sorour Neamatpour 5 and Mohammadreza Afsharmanesh 6
Authors Information
1 Nutrition and Metabolic Disease Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Nutrition, Health Research Institute, Diabetes Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Food Security Research Center, Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran
4 Department of Biostatistics and Epidemiology, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5 Department of Psychiatry, Golestan Medical Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
6 Department of Biochemistry, Hyperlipidaemia Research Centre, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 2017, 11 (2); e7790
  • Published Online: December 19, 2016
  • Article Type: Original Article
  • Received: July 5, 2016
  • Revised: October 18, 2016
  • Accepted: December 9, 2016
  • DOI: 10.5812/ijpbs.7790

To Cite: Hashemi S, Amani R, Cheraghian B, Neamatpour S, Afsharmanesh M. Association of Serum Vitamin D and Total Antioxidant Capacity Levels With Stress and Anxiety in Young Female Students, Iran J Psychiatry Behav Sci. 2017 ; 11(2):e7790. doi: 10.5812/ijpbs.7790.

Abstract
Copyright © 2016, Mazandaran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. objectives
3. Materials and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Weinberger DR. Anxiety at the frontier of molecular medicine. N Engl J Med. 2001; 344(16): 1247-9[DOI][PubMed]
  • 2. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Van Rompay M, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA. 1998; 280(18): 1569-75[PubMed]
  • 3. Gross C, Hen R. The developmental origins of anxiety. Nat Rev Neurosci. 2004; 5(7): 545-52[DOI][PubMed]
  • 4. Mohammadi MR, Davidian H, Noorbala AA, Malekafzali H, Naghavi HR, Pouretemad HR, et al. An epidemiological survey of psychiatric disorders in Iran. Clin Pract Epidemiol Ment Health. 2005; 1: 16[DOI][PubMed]
  • 5. de Graaf R, Bijl RV, Smit F, Vollebergh WA, Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry. 2002; 159(4): 620-9[DOI][PubMed]
  • 6. Issakidis C, Andrews G. Service utilisation for anxiety in an Australian community sample. Soc Psychiatry Psychiatr Epidemiol. 2002; 37(4): 153-63[PubMed]
  • 7. Huang JY, Arnold D, Qiu CF, Miller RS, Williams MA, Enquobahrie DA. Association of serum vitamin D with symptoms of depression and anxiety in early pregnancy. J Womens Health (Larchmt). 2014; 23(7): 588-95[DOI][PubMed]
  • 8. Calvo MS, Whiting SJ, Barton CN. Vitamin D intake: a global perspective of current status. J Nutr. 2005; 135(2): 310-6[PubMed]
  • 9. Hashemipour S, Larijani B, Adibi H, Javadi E, Sedaghat M, Pajouhi M, et al. Vitamin D deficiency and causative factors in the population of Tehran. BMC Public Health. 2004; 4: 38[DOI][PubMed]
  • 10. Eyles DW, Feron F, Cui X, Kesby JP, Harms LH, Ko P, et al. Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology. 2009; 34 Suppl 1-57[DOI][PubMed]
  • 11. McCann JC, Ames BN. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction? FASEB J. 2008; 22(4): 982-1001[DOI][PubMed]
  • 12. Stumpf WE, Sar M, Clark SA, DeLuca HF. Brain target sites for 1,25-dihydroxyvitamin D3. Science. 1982; 215(4538): 1403-5[PubMed]
  • 13. Walbert T, Jirikowski GF, Prufer K. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat. Horm Metab Res. 2001; 33(9): 525-31[DOI][PubMed]
  • 14. Neveu I, Naveilhan P, Menaa C, Wion D, Brachet P, Garabedian M. Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro. J Neurosci Res. 1994; 38(2): 214-20[DOI][PubMed]
  • 15. Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care. 2007; 10(1): 12-9[DOI][PubMed]
  • 16. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006; 14(12): 1032-40[DOI][PubMed]
  • 17. Przybelski RJ, Binkley NC. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch Biochem Biophys. 2007; 460(2): 202-5[DOI][PubMed]
  • 18. Llewellyn DJ, Langa KM, Lang IA. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J Geriatr Psychiatry Neurol. 2009; 22(3): 188-95[DOI][PubMed]
  • 19. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology. 2010; 74(1): 18-26[DOI][PubMed]
  • 20. Hedelin M, Lof M, Olsson M, Lewander T, Nilsson B, Hultman CM, et al. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33,000 women from the general population. BMC Psychiatry. 2010; 10: 38[DOI][PubMed]
  • 21. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport. 2004; 15(8): 1271-4[PubMed]
  • 22. Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res. 2005; 157(2): 299-308[DOI][PubMed]
  • 23. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol. 2007; 26(4): 551-4[DOI][PubMed]
  • 24. Dean AJ, Bellgrove MA, Hall T, Phan WM, Eyles DW, Kvaskoff D, et al. Effects of vitamin D supplementation on cognitive and emotional functioning in young adults--a randomised controlled trial. PLoS One. 2011; 6(11)[DOI][PubMed]
  • 25. Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B. Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder. Neuropsychobiology. 2002; 46(1): 27-32[PubMed]
  • 26. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol. 2007; 39(1): 44-84[DOI][PubMed]
  • 27. Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J Neuropsychopharmacol. 2008; 11(6): 851-76[DOI][PubMed]
  • 28. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem. 2006; 97(6): 1634-58[DOI][PubMed]
  • 29. Delattre J, Beaudeux JL, Bonnefont-Rousselot D. Radicaux libres et stress oxydant(aspects biologiques et pathologiques). 2005;
  • 30. Filiou MD, Zhang Y, Teplytska L, Reckow S, Gormanns P, Maccarrone G, et al. Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways. Biol Psychiatry. 2011; 70(11): 1074-82[DOI][PubMed]
  • 31. Mazloom Z, Ekramzadeh M, Hejazi N. Efficacy of supplementary vitamins C and E on anxiety, depression and stress in type 2 diabetic patients: a randomized, single-blind, placebo-controlled trial. Pak J Biol Sci. 2013; 16(22): 1597-600[PubMed]
  • 32. Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther. 1995; 33(3): 335-43[PubMed]
  • 33. Henry JD, Crawford JR. The short-form version of the Depression Anxiety Stress Scales (DASS-21): construct validity and normative data in a large non-clinical sample. Br J Clin Psychol. 2005; 44: 227-39[DOI][PubMed]
  • 34. Crawford JR, Henry JD. The Depression Anxiety Stress Scales (DASS): normative data and latent structure in a large non-clinical sample. Br J Clin Psychol. 2003; 42: 111-31[DOI][PubMed]
  • 35. Maddock J, Berry DJ, Geoffroy MC, Power C, Hypponen E. Vitamin D and common mental disorders in mid-life: cross-sectional and prospective findings. Clin Nutr. 2013; 32(5): 758-64[DOI][PubMed]
  • 36. van der Schaft J, Koek HL, Dijkstra E, Verhaar HJ, van der Schouw YT, Emmelot-Vonk MH. The association between vitamin D and cognition: a systematic review. Ageing Res Rev. 2013; 12(4): 1013-23[DOI][PubMed]
  • 37. Chei CL, Raman P, Yin ZX, Shi XM, Zeng Y, Matchar DB. Vitamin D levels and cognition in elderly adults in China. J Am Geriatr Soc. 2014; 62(11): 2125-9[DOI][PubMed]
  • 38. Millet P, Landel V, Virard I, Morello M, Feron F. [Role of vitamin D in the physiopathology of neurodegenerative diseases]. Biol Aujourdhui. 2014; 208(1): 77-88[DOI][PubMed]
  • 39. Thouvenot E, Camu W. [Vitamin D and neurology]. Presse Med. 2013; 42(10): 1398-404[DOI][PubMed]
  • 40. Gowda U, Mutowo MP, Smith BJ, Wluka AE, Renzaho AM. Vitamin D supplementation to reduce depression in adults: meta-analysis of randomized controlled trials. Nutrition. 2015; 31(3): 421-9[DOI][PubMed]
  • 41. Sanders KM, Stuart AL, Williamson EJ, Jacka FN, Dodd S, Nicholson G, et al. Annual high-dose vitamin D3 and mental well-being: randomised controlled trial. Br J Psychiatry. 2011; 198(5): 357-64[DOI][PubMed]
  • 42. Guney E, Fatih Ceylan M, Tektas A, Alisik M, Ergin M, Goker Z, et al. Oxidative stress in children and adolescents with anxiety disorders. J Affect Disord. 2014; 156: 62-6[DOI][PubMed]
  • 43. Hovatta I, Juhila J, Donner J. Oxidative stress in anxiety and comorbid disorders. Neurosci Res. 2010; 68(4): 261-75[DOI][PubMed]
  • 44. Bouayed J, Rammal H, Soulimani R. Oxidative stress and anxiety: relationship and cellular pathways. Oxid Med Cell Longev. 2009; 2(2): 63-7[PubMed]
  • 45. Bouayed J. Polyphenols: A Potential New Strategy for the Prevention and Treatment of Anxiety and Depression. Curr Nutr Food Sci. 2010; 6(1): 13-8[DOI]
  • 46. Macht M, Mueller J. Immediate effects of chocolate on experimentally induced mood states. Appetite. 2007; 49(3): 667-74[DOI][PubMed]
  • 47. Zellner DA, Loaiza S, Gonzalez Z, Pita J, Morales J, Pecora D, et al. Food selection changes under stress. Physiol Behav. 2006; 87(4): 789-93[DOI][PubMed]
  • 48. Christensen L, Brooks A. Changing food preference as a function of mood. J Psychol. 2006; 140(4): 293-306[DOI][PubMed]
  • 49. Crichton GE, Murphy KJ, Bryan J. Dairy intake and cognitive health in middle-aged South Australians. Asia Pac J Clin Nutr. 2010; 19(2): 161-71[PubMed]
  • 50. Sanchez-Villegas A, Verberne L, De Irala J, Ruiz-Canela M, Toledo E, Serra-Majem L, et al. Dietary fat intake and the risk of depression: the SUN Project. PLoS One. 2011; 6(1)[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments